✨ Health, Trade Notices
NEW ZEALAND GAZETTE, No. 53 — 9 JUNE 2016
Product:
Clopine
Active Ingredient:
Clozapine 50mg/mL
Dosage Form:
Oral suspension
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Douglas Manufacturing Limited, Auckland, New Zealand
Note: This consent is given subject to the following conditions:
-
The medicine may only be prescribed by:
- A medical practitioner who is vocationally registered by the Medical Council of New Zealand in the scope of practice of psychiatry (“Psychiatrist”).
- A medical practitioner or nurse practitioner who is prescribing under the supervision of a Psychiatrist.
- A medical practitioner who is registered by the Medical Council of New Zealand in a general scope of practice provided the medical practitioner is prescribing clozapine for a patient whose illness is being well controlled by clozapine and the prescribing decision is taken in collaboration with, or following consultation with, a Community Mental Health Team.
-
Persons prescribing the medicine must comply with appropriate local treatment guidelines.
-
The medicine must be dispensed in accordance with appropriate local dispensing guidelines.
-
Sale or marketing of this medicine may only occur if the sponsor has an appropriate blood monitoring and patient record database in place.
Also note: This renewed consent is valid for two years from 10 July 2016.
Dated this 2nd day of June 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go3233
Appointment of Director of Area Mental Health Services
Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Chai Chuah, Director-General of Health, issue the following notice, effective from 10 June 2016.
This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Act Notice 2013 – Appointment of Directors of Area Mental Health Services (“principal notice”), as published in the New Zealand Gazette, 17 October 2013, No. 143, page 3909.
Schedule 1 to the principal notice is amended in respect of “Counties Manukau DHB” by omitting the name and title
“Muther Sastry Anand, psychiatrist, of Auckland”
and substituting the name and title
“Mark Wilkinson Fisher, consultant psychiatrist, of Auckland”.
Dated at Wellington this 2nd day of June 2016.
CHAI CHUAH, Director-General of Health.
2016-go3239
Cessation of Anti-Dumping Duties on Wire Nails From the People’s Republic of China
The Ministry of Business, Innovation and Employment gives notice that, in terms of section 14(9) of the Dumping and Countervailing Duties Act 1988, anti-dumping duties on wire nails from China ceased to be payable with effect from 2 June 2016.
These duties were suspended, for three years, with effect from 1 June 2014, therefore, no anti-dumping duty was being collected during the suspension period.
33
Next Page →
NZ Gazette 2016, No 53
✨ LLM interpretation of page content
🏥
Renewal of Provisional Consent to the Distribution of Clopine
(continued from previous page)
🏥 Health & Social Welfare2 June 2016
Medicines, Renewal, Clopine, Clozapine, Provisional Consent, Prescription, Mental Health
- Chris James, Acting Group Manager, Medsafe, Ministry of Health
🏥 Appointment of Director of Area Mental Health Services
🏥 Health & Social Welfare2 June 2016
Appointment, Director, Mental Health Services, Counties Manukau DHB, Psychiatrist
- Muther Sastry Anand (psychiatrist), Replaced as Director of Area Mental Health Services
- Mark Wilkinson Fisher (consultant psychiatrist), Appointed as Director of Area Mental Health Services
- Chai Chuah, Director-General of Health
🏭 Cessation of Anti-Dumping Duties on Wire Nails From the People’s Republic of China
🏭 Trade, Customs & IndustryTrade, Anti-Dumping Duties, Wire Nails, China, Cessation